BLUE logo

bluebird bio, Inc. (BLUE)

Profile

Full Name

bluebird bio, Inc.

Ticker

NASDAQ: BLUE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2013

Indexes

Not included

Website

https://www.bluebirdbio.com

Employees

248

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$83.81M(+184.12% YoY)

Annual EPS

-$24.84(+35.63% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    BLUE price value is unknown

    30-Day Relative Volume

    -
    BLUE 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    BLUE price change on Jan 1, 1 is unknown

    Price YTD change

    -
    BLUE price ytd change is unknown

    Price 1-year change

    -
    BLUE price 1-year change is unknown

    Price 3-year change

    -
    BLUE price 3-year change is unknown

    Price Range

    Price All-time high

    $3057.64
    BLUE price is currently at an all-time high

    Price 3-year low

    $3.20
    BLUE price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    BLUE market capitalization value is unknown

    Market cap 3-year change

    -
    BLUE market capitalization 3-year change is unknown

    Market cap All-time high

    $7.54B
    BLUE market capitalization is currently at an all-time high

    Market cap sector rank

    -
    BLUE market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1%
    BLUE shares outstanding is up +1% year-on-year

    Shares Outstanding 3-Year Change

    +153.95%
    BLUE shares outstanding is up +153.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    BLUE beta value is unknown

    200-day SMA

    -
    BLUE SMA 200 is unknown

    50-day SMA

    -
    BLUE SMA 50 is unknown

    RSI

    -
    BLUE 14-day relative strength index value is unknown

    Volume

    -
    BLUE 30-day relative volume value is unknown

    ATR

    -
    BLUE average true range value is unknown

    10-day Historical Volatility

    -
    BLUE 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $83.81M
    BLUE annual revenue is $83.81 million

    Revenue Analysts estimate

    $154.52M
    BLUE annual revenue is currently -45.76% lower than the consensus analysts' forecast

    Revenue 1-year change

    +184.12%
    BLUE annual revenue is up +184.12% year-on-year

    Revenue Sector rank

    -
    BLUE annual revenue is unknown

    EPS

    EPS

    -$24.84
    BLUE annual earnings per share is -$24.84

    EPS Analysts estimate

    -$11.28
    BLUE annual earnings per share is currently +120.21% higher than the consensus analysts' forecast

    EPS 1-year change

    +35.63%
    BLUE annual earnings per share is up +35.63% year-on-year

    EPS Sector rank

    -
    BLUE annual earnings per share is unknown

    Profit

    Gross profit

    -$5.57M
    BLUE annual gross profit is -$5.57 million

    Gross margin

    -6.65%
    BLUE annual gross profit margin is -6.65%

    Operating profit

    -$267.70M
    BLUE annual operating income is -$267.70 million

    Operating margin

    -319.42%
    BLUE annual operating profit margin is -319.42%

    Net income

    -$240.72M
    BLUE annual net profit is -$240.72 million

    Net margin

    -287.23%
    BLUE annual net profit margin is -287.23%

    Expenses

    Total expenses

    $351.51M
    BLUE annual total expenses is $351.51 million

    Operating expenses

    $262.13M
    BLUE annual total operating expenses is $262.13 million

    Cost of goods sold

    $89.38M
    BLUE annual cost of goods sold is $89.38 million

    Selling, general & administrative expenses

    $167.87M
    BLUE annual SGA is $167.87 million

    Depreciation and amortization

    $61.24M
    BLUE annual depreciation & amortization is $61.24 million

    Interest expense

    $22.58M
    BLUE annual interest expense is $22.58 million

    Income tax

    $70.00K
    BLUE annual income tax is $70.00 thousand

    EBIT & EBITDA

    EBIT

    -$218.07M
    BLUE annual earnings before interest & taxes is -$218.07 million

    EBITDA

    -$156.82M
    BLUE annual EBITDA is -$156.82 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $460.23M
    BLUE annual total assets is $460.23 million

    Non current assets

    $305.56M
    BLUE annual long term assets is $305.56 million

    Current assets

    $154.67M
    BLUE annual total current assets is $154.67 million

    Cash and cash equivalents

    $62.30M
    BLUE annual cash & cash equivalents is $62.30 million

    Accounts receivable

    $13.62M
    BLUE annual accounts receivable is $13.62 million

    Inventory

    $65.02M
    BLUE annual inventory is $65.02 million

    Liabilities

    Total liabilities

    $491.77M
    BLUE annual total liabilities is $491.77 million

    Long term liabilities

    $170.30M
    BLUE annual total long term liabilities is $170.30 million

    Current liabilities

    $321.46M
    BLUE annual total current liabilities is $321.46 million

    Accounts payable

    $34.32M
    BLUE annual accounts payable is $34.32 million

    Debt

    Total debt

    $358.24M
    BLUE annual total debt is $358.24 million

    Total debt 1-year change

    +7.37%
    BLUE annual total debt is up +7.37% year-on-year

    Long term debt

    $169.36M
    BLUE annual long term debt is $169.36 million

    Short term debt

    $188.88M
    BLUE annual short term debt is $188.88 million

    Equity & Capital

    Shareholders equity

    -$31.53M
    BLUE annual stockholders equity is -$31.53 million

    Book value

    -$31.53M
    BLUE annual book value is -$31.53 million

    Retained earnings

    -$4.50B
    BLUE annual retained earnings is -$4.50 billion

    Working capital

    -$166.79M
    BLUE annual working capital is -$166.79 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$260.02M
    BLUE annual cash flow from operations is -$260.02 million

    Cash from operations 1-year change

    -10.63%
    BLUE annual cash flow from operations is down -10.63% year-on-year

    Cash from investing

    $3.90M
    BLUE annual cash flow from investing activities is $3.90 million

    Cash from investing 1-year change

    -97.48%
    BLUE annual cash flow from investing activities is down -97.48% year-on-year

    Cash from financing

    $87.47M
    BLUE annual cash flow from financing activities is $87.47 million

    Cash from financing 1-year change

    -55.43%
    BLUE annual cash flow from financing activities is down -55.43% year-on-year

    CAPEX

    CAPEX

    $2.60M
    BLUE annual capital expenditures is $2.60 million

    CAPEX 1-year change

    -71.3%
    BLUE annual capital expenditures is down -71.3% year-on-year

    Free Cash Flow

    Free cash flow

    -$262.62M
    BLUE annual free cash flow is -$262.62 million

    Free cash flow 1-year change

    -7.59%
    BLUE annual free cash flow is down -7.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -6.65%
    BLUE annual gross profit margin is -6.65%

    Operating margin

    -319.42%
    BLUE annual operating profit margin is -319.42%

    Net margin

    -287.23%
    BLUE annual net profit margin is -287.23%

    ROA & ROE

    ROA

    -44.60%
    BLUE annual return on assets is -44.60%

    ROE

    -295.35%
    BLUE annual return on equity is -295.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BLUE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BLUE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    BLUE price to book ratio value is unknown

    PB ratio Sector rank

    -
    BLUE price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    BLUE price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BLUE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    BLUE enterprise value value is unknown

    Enterprise value Sector rank

    -
    BLUE enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    BLUE EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    BLUE EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.48
    BLUE annual current ratio is 0.48

    Quick ratio

    0.28
    BLUE annual quick ratio is 0.28

    Leverage

    Debt to equity

    -2.27
    BLUE annual debt to equity ratio is -2.27

    Interest coverage ratio

    -9.66
    BLUE annual interest coverage ratio is -9.66

    Risk & Stability

    Piotroski F-Score

    3
    BLUE piotroski f-score is 3

    Altman Z-Score

    -
    BLUE altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Mar 31, 25 Barclays
    Overweight
    Feb 24, 25 Wells Fargo
    Equal-Weight
    Feb 24, 25 JP Morgan
    Neutral
    Dec 31, 24 Barclays
    Overweight
    Nov 15, 24 RBC Capital
    Sector Perform
    Nov 15, 24 Barclays
    Overweight
    Nov 15, 24 B of A Securities
    Neutral
    Sep 25, 24 Wells Fargo
    Equal-Weight
    Sep 16, 24 Cantor Fitzgerald
    Neutral
    Aug 15, 24 RBC Capital
    Sector Perform

    Institutional Ownership

    Screeners with BLUE included

    No data
    • What is the ticker symbol for bluebird bio, Inc.?
    • Does bluebird bio, Inc. pay dividends?
    • What sector is bluebird bio, Inc. in?
    • What industry is bluebird bio, Inc. in?
    • What country is bluebird bio, Inc. based in?
    • When did bluebird bio, Inc. go public?
    • Is bluebird bio, Inc. in the S&P 500?
    • Is bluebird bio, Inc. in the NASDAQ 100?
    • Is bluebird bio, Inc. in the Dow Jones?
    • When was bluebird bio, Inc.'s last earnings report?
    • When does bluebird bio, Inc. report earnings?

    What is the ticker symbol for bluebird bio, Inc.?

    The ticker symbol for bluebird bio, Inc. is NASDAQ:BLUE

    Does bluebird bio, Inc. pay dividends?

    No, bluebird bio, Inc. does not pay dividends

    What sector is bluebird bio, Inc. in?

    bluebird bio, Inc. is in the Healthcare sector

    What industry is bluebird bio, Inc. in?

    bluebird bio, Inc. is in the Biotechnology industry

    What country is bluebird bio, Inc. based in?

    bluebird bio, Inc. is headquartered in United States

    When did bluebird bio, Inc. go public?

    bluebird bio, Inc.'s initial public offering (IPO) was on June 19, 2013

    Is bluebird bio, Inc. in the S&P 500?

    No, bluebird bio, Inc. is not included in the S&P 500 index

    Is bluebird bio, Inc. in the NASDAQ 100?

    No, bluebird bio, Inc. is not included in the NASDAQ 100 index

    Is bluebird bio, Inc. in the Dow Jones?

    No, bluebird bio, Inc. is not included in the Dow Jones index

    When was bluebird bio, Inc.'s last earnings report?

    bluebird bio, Inc.'s most recent earnings report was on August 14, 2025

    When does bluebird bio, Inc. report earnings?

    The date for bluebird bio, Inc.'s next earnings report has not been announced yet
    On this page